Christian Angermayer's Net Worth
$0
Who is Christian Angermayer?
Christian Angermayer does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Alto Neuroscience, Inc., ATAI Life Sciences N.V., Sensei Biotherapeutics, Inc., and Frontier Acquisition Corp..
SEC CIK
Christian Angermayer's CIK is 0001845872
Past Insider Trading and Trends
2024 was Christian Angermayer's most active year for acquiring shares with 2 total transactions. Christian Angermayer's most active month to acquire stocks was the month of April. 2024 saw Christian Angermayer paying a total of $0.00 for 745,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Alto Neuroscience, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 926.54K |
—
|
—
| 926.54K |
Feb 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ATAI Life Sciences N.V. (ATAI) Snapshot price: $1.1849
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
| +3.93% | 1.21M |
$1.32 | $1,600,443.45 | 32.09M |
Mar 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
| +9.22% | 136.39K |
$5.02 | $684,553.43 | 1.61M |
Apr 20 - Apr 21
| |||
Form 4
| +3.25% | 56.6K |
$4.46 | $252,490.15 | 1.8M |
Apr 28 - Apr 29
| |||
Form 4
| +3.94% | 66.01K |
$4.67 | $308,567.05 | 1.74M |
Apr 26 - Apr 27
| |||
Form 4
| +3.83% | 61.78K |
$4.82 | $297,804.68 | 1.68M |
Apr 22 - Apr 25
| |||
Form 4
| +8.80% | 119.64K |
$5.12 | $612,395.41 | 1.48M |
Apr 18 - Apr 19
| |||
Form 4
| +0.37% | 4.97K |
$5.19 | $25,778.73 | 1.36M |
Apr 14
| |||
Form 4
| +4.25% | 55.2K |
$4.88 | $269,560.07 | 1.35M |
Apr 12
| |||
Form 4
| +9.40% | 111.61K |
$4.82 | $538,194.10 | 1.3M |
Apr 8 - Apr 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 10
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +3.59% | 700K |
$15.00 | $10,500,000.00 | 20.19M |
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sensei Biotherapeutics, Inc. (SNSE) Snapshot price: $0.58
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.44M |
$1.58 | -$5,437,824.38 |
0
|
Jun 1
| |||
Form 4
| +0.09% | 2.2K |
$1.61 | $3,539.03 | 2.49M |
Feb 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Frontier Acquisition Corp. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||